Articles with "seqirus usa" as a keyword



P-2055. Modelling the Relative Vaccine Effectiveness of ARCT-154 versus BNT162b2 in Younger and Older Adults

Sign Up to like & get
recommendations!
Published in 2025 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofae631.2211

Abstract: Abstract Background While vaccines have proved a key tool in protection from COVID-19, the duration of immunity induced by first-generation mRNA vaccines is limited. Self-amplifying mRNA (SA-mRNA) vaccines have clinically shown to both elicit higher… read more here.

Keywords: arct 154; csl; seqirus usa; stocks bonds ... See more keywords

P-28. A Clinical and Economic Comparison of Non-Egg Influenza Vaccines in Adults 18-64 Years in the U.S

Sign Up to like & get
recommendations!
Published in 2025 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofae631.235

Abstract: Abstract Background Influenza vaccination with non-egg-based vaccines had improved the antibody response to circulating flu viruses over that of traditional egg-based vaccines, which are the most common flu vaccines worldwide. Two non-egg-based flu vaccines— the… read more here.

Keywords: seqirus; non egg; seqirus usa; usa advisor ... See more keywords